Skip to content
Disclosery

Finepoint Capital LP

Follow

13F filer, CIK 1608126, BOSTON, MA

Finepoint Capital LP reported $1,355,564,277 across 10 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000904454-25-000412

Period
2025-06-30
Reported value
$1.36B
Holdings
10
Top 10 weight
100%
New
0
Sold out
15

Largest buys vs the previous quarter

SecurityShares changeApprox. value
LLYVKadded+104,156$8.45M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
QXOreduced-3,315,292-$71.4M
LBRDKexited-529,240-$45M
SPRINGWORKS THERAPEUTICS INCexited-728,602-$32.2M
ASNDexited-179,872-$28M
RVMDexited-691,260-$24.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0000904454-25-000412, largest first. % of portfolio is the value over $504,280,152, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
QXOQXO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,750,781 shares; 2024Q4: 24,933,825 shares; 2025Q1: 24,468,160 shares; 2025Q2: 21,152,868 shares 21,152,868$456M90.35%-3,315,292Timeline
LLYVKLIBERTY MEDIA CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 812,792 shares; 2025Q1: 432,895 shares; 2025Q2: 537,051 shares 537,051$43.6M8.64%+104,156Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 961,251 shares; 2024Q4: 961,251 shares; 2025Q1: 961,251 shares; 2025Q2: 961,251 shares 961,251$4.68M0.93%0Timeline
ANNAALEANNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 27,717 shares; 2025Q1: 27,717 shares; 2025Q2: 27,717 shares 27,717$200K0.04%0Timeline
ANNAWALEANNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 490,000 shares; 2025Q1: 490,000 shares; 2025Q2: 490,000 shares 490,000$115K0.02%0Timeline
MNYWWMONEYHERO LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 895,000 shares; 2024Q4: 895,000 shares; 2025Q1: 895,000 shares; 2025Q2: 895,000 shares 895,000$41.9K0.01%0Timeline
SUMMIT HEALTHCARE ACQUISITI…SUMMIT HEALTHCARE ACQUISITIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 489,999 shares; 2024Q4: 489,999 shares; 2025Q1: 489,999 shares; 2025Q2: 489,999 shares 489,999$19.6K<0.01%0
CALIDI BIOTHERAPEUTICS INCCALIDI BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,500 shares; 2024Q4: 12,500 shares; 2025Q1: 12,499 shares; 2025Q2: 12,499 shares 12,499$2.88K<0.01%0

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SPYSTATE STR SPDR S&P 500 ETF T SHSput1,173,500$725M+418,500
IWMISHARES TR SHSput585,000$126M-900,000

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
LBRDKLIBERTY BROADBAND CORP529,240$45Mshares
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC728,602$32.2Mshares
ASNDASCENDIS PHARMA A/S179,872$28Mshares
RVMDREVOLUTION MEDICINES INC691,260$24.4Mshares
MLTXMOONLAKE IMMUNOTHERAPEUTICS435,785$17Mshares
LKFTLAKEFRONT BIOTHERAPEUTICS NV656,587$16.5Mshares
CYTKCYTOKINETICS INC309,948$12.5Mshares
RNAMAVIDITY BIOSCIENCES INC380,700$11.2Mshares
SRPTSAREPTA THERAPEUTICS INC157,555$10.1Mshares
PRTAPROTHENA CORP PLC640,071$7.92Mshares
XNCRXENCOR INC642,200$6.83Mshares
EYPTEYEPOINT INC1,081,954$5.86Mshares
RLAYRELAY THERAPEUTICS INC2,117,646$5.55Mshares
ARVNARVINAS INC694,028$4.87Mshares
MARBLEGATE ACQUISITION CORPMARBLEGATE ACQUISITION CORP735,000$118Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000904454-25-000412 base2025-08-13acceptance time not in the bulk data set